Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hallucinations in Parkinson's disease. prevalence, phenomenology and risk factors. Fenelon G* mahieux F, huon R, Ziegler M. Brain 2000;123:733-745

Literature DB >> 11004314

Hallucinations in Parkinson's disease. prevalence, phenomenology and risk factors. Fenelon G* mahieux F, huon R, Ziegler M. Brain 2000;123:733-745

Abstract

Entities: Chemical Disease

Year: 2000 PMID： 11004314

Source DB: PubMed Journal: Am J Ophthalmol ISSN： 0002-9394 Impact factor: 5.258

Keyword Cloud
Cited

× No keyword cloud information.

47 in total

1. Co-occurrence of affective and schizophrenia spectrum disorders with PINK1 mutations.

Authors: Susanne Steinlechner; Jessica Stahlberg; Birgit Völkel; Ana Djarmati; Johann Hagenah; Anja Hiller; Katja Hedrich; Inke König; Christine Klein; Rebekka Lencer
Journal: J Neurol Neurosurg Psychiatry Date: 2007-01-03 Impact factor: 10.154

Review 2. Antiparkinsonian medication and pathological gambling.

Authors: Malcolm Lader
Journal: CNS Drugs Date: 2008 Impact factor: 5.749

Review 3. Cortical afferent inhibition abnormalities reveal cholinergic dysfunction in Parkinson's disease: a reappraisal.

Authors: Raffaele Nardone; Francesco Brigo; Viviana Versace; Yvonne Höller; Frediano Tezzon; Leopold Saltuari; Eugen Trinka; Luca Sebastianelli
Journal: J Neural Transm (Vienna) Date: 2017-08-12 Impact factor: 3.575

Review 4. [Nonmotor symptoms in Parkinson's disease].

Authors: W H Jost
Journal: Nervenarzt Date: 2017-08 Impact factor: 1.214

5. Prevalence of psychotic symptoms in a community-based Parkinson disease sample.

Authors: Joel Mack; Peter Rabins; Karen Anderson; Susanne Goldstein; Stephen Grill; Elaina S Hirsch; Susan Lehmann; John T Little; Russell L Margolis; Justin Palanci; Gregory Pontone; Howard Weiss; James R Williams; Laura Marsh
Journal: Am J Geriatr Psychiatry Date: 2012-02 Impact factor: 4.105

Review 6. [Parkinson's disease and psychoses].

Authors: Jacopo Vittoriano Bizzarri; Giancarlo Giupponi; Ignazio Maniscalco; Patrizia Schroffenegger; Andreas Conca; Hans Peter Kapfhammer
Journal: Neuropsychiatr Date: 2015-01-14

Hallucinations in Parkinson's disease. prevalence, phenomenology and risk factors. Fenelon G* mahieux F, huon R, Ziegler M. Brain 2000;123:733-745

1. Co-occurrence of affective and schizophrenia spectrum disorders with PINK1 mutations.

Review 2. Antiparkinsonian medication and pathological gambling.

Review 3. Cortical afferent inhibition abnormalities reveal cholinergic dysfunction in Parkinson's disease: a reappraisal.

Review 4. [Nonmotor symptoms in Parkinson's disease].

5. Prevalence of psychotic symptoms in a community-based Parkinson disease sample.

Review 6. [Parkinson's disease and psychoses].

Review 7. Clinical review and treatment of select adverse effects of dopamine receptor agonists in Parkinson's disease.

Review 8. Visual hallucinations and the Charles Bonnet syndrome.

Review 9. Management of non-motor complications in Parkinson's disease.

10. Use of antipsychotics in older home care patients in Finland.